A Comparison of 18 F-FDG PET/CT and 68 Ga-PSMA PET/CT in Detecting Osteonecrosis of the Jaw in a Patient With Prostate Cancer.
Clin Nucl Med
; 49(2): e68-e69, 2024 Feb 01.
Article
em En
| MEDLINE
| ID: mdl-38170920
ABSTRACT
ABSTRACT Medication-related osteonecrosis of the jaw (ONJ) is rare adverse effect of zoledronic acid. We present ONJ detected in a 65-year-old man with prostate cancer who underwent 18 F-FDG PET/CT for metabolic characterization and to exclude a second primary malignancy of the liver lesion observed in 68 Ga-PSMA PET/CT. ONJ has high metabolic activity on 18 F-FDG PET/CT and no PSMA receptor activation on the 68 Ga-PSMA PET/CT. In this case, we wanted to underline the importance of 18 F-FDG PET/CT imaging of medication-related ONJ in patients receiving zoledronic acid therapy and to emphasize that rapid and appropriate treatment can be provided.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Osteonecrose
/
Neoplasias da Próstata
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article